This week on the Rated Rx Podcast, Robbie Abasi, Sam Llona, and Xavier Hill break down the FDA’s new GLP-1 “green list” for compounding. You’ll hear why it raises quality standards and why patients will pay more.
They talk through tough ethical calls: forced treatment in psychiatry, anticoagulation in gray cases, opioid management, and assisted suicide. You’ll see how their approach has shifted since graduation—less about memorizing the book, more about clinical judgment and emotional intelligence. They share advice for students and new grads: manage imposter syndrome, find mentors, set boundaries, and say no when needed.
In Pharmacy Fantasy, they fix a “smart pill organizer” that makes life harder instead of easier. In the Blind Draft, they rank supplement label claims, from “immune to STDs on leap years” to other wild promises. They close with Adverse Reactions, where a patient celebrates paying “only” $120 a month for prescriptions. That sparks a real talk about drug prices, insurance gaps, and oversharing personal health information online.
This podcast is intended for entertainment and informational purposes only.
Hosted on Acast. See acast.com/privacy for more information.
